Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-041809

General Counsel sold 368 shares at $0.77 ($284)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-02 Sale : show line 1 in the form −368 $0.77 $284 224,610 D
Open-market sales · 368 sh · avg $0.77 · $284
Loading xslF345X05/ownership.xml…